Publications

Cost Recovery Implementation Statement – Administration of the Prescribed List of Medical Devices and Human Tissue Products

This cost recovery implementation statement describes how the Department of Health and Aged Care recovers the costs of administering the Prescribed List from 1 July 2025 to 30 June 2026.

Scroll down to access downloads and media.

Cost Recovery Implementation Statement – Administration of the Prescribed List of Medical Devices and Human Tissue Products

Cost Recovery Implementation Statement – Administration of the Prescribed List of Medical Devices and Human Tissue Products [PDF - 485 KB] - 20 pages

Cost Recovery Implementation Statement – Administration of the Prescribed List of Medical Devices and Human Tissue Products [Word - 139 KB] - 20 pages

About this resource

Publication date:

2 July 2025

Publication type:

Report

Language:

English

Part of a collection:

Cost Recovery Implementation Statement (CRIS)

Tags:

Health technologies and digital health
Medical devices
Private health insurance

Sub menu

Cost Recovery Implementation Statement – Administration of the Prescribed List of Medical Devices and Human Tissue Products

Cost Recovery Implementation Statement – Administration of the Prescribed List of Medical Devices and Human Tissue Products

About this resource

Help us improve health.gov.au